Goldman Richter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Disappointment about the construction of a drug trial has caused Vertex stock to fall. Better times may be ahead.

San diegoUnited statesSalveen richterDanielle brillGoldman richterJacob sonenshineRaymond jamesBrian abrahamsEvan seigermanPolaris market researchCourtesy vertex pharmaceuticals incorporatedGoldman sachsVertex pharmaceuticalsPolaris marketCystic fibrosisArticle normal